Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial
机构：[1]Sun Yat-sen University Cancer Center, Guangzhou, China[2]Department of Lymphoma, Guizhou Cancer Hospital, The AffiliatedCancer Hospital of Guizhou Medical University, Guiyang, China[3]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China[4]Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China浙江省肿瘤医院[5]Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China[6]Yunnan Cancer Hospital, Kunming, China[7]Tumor hospital affiliated to Guangzhou Medical University, Guangzhou, CHN[8]Henan tumor hospital, Zhengzhou, CHN河南省肿瘤医院[9]The First Hospital of China Medical University, Shenyang, China,Shenyang, China[10]Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院[11]Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China[12]Peking University Third Hospital, Beijing, China[13]First Affiliated Hospital of Guangxi Medical University, NANING, CHN[14]Hubei Cancer Hospital, Wuhan, CHN[15]The Fist Affiliated Hospital of Nanchang University, Jiangxi, China[16]Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China[17]Department of Hematology, The Second Affiliated Hospitalof Zhejiang University School of Medicine, Zhejiang, China[18]blood diseasea hospital, Tianjin, CHN[19]Sun Yat-sen Memorial,Sun Yat-sen University, GUANGZHOU, CHN[20]CSPC ZhongQi Pharmaceutical Technology Co, Shijiazhuang, China
第一作者机构：[1]Sun Yat-sen University Cancer Center, Guangzhou, China
推荐引用方式(GB/T 7714)：
Huang Hui-qiang,Huang Yunhong,Yan Gao,et al.Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial[J].BLOOD.2019,134:doi:10.1182/blood-2019-126481.
APA：
Huang, Hui-qiang,Huang, Yunhong,Yan, Gao,Yang, Haiyan,Zhang, Qingyuan...&Xue, Jianfei.(2019).Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial.BLOOD,134,
MLA：
Huang, Hui-qiang,et al."Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial".BLOOD 134.(2019)
医学